CytomX Therapeutics (CTMX) Operating Margin (2014 - 2026)
CytomX Therapeutics (CTMX) reported Operating Margin of -1677.08% for Q2 2026, down 1670.19 percentage points from -6.89% a year earlier and down 1485.31 percentage points from the prior quarter.
CytomX Therapeutics (CTMX) Operating Margin (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CytomX Therapeutics' Operating Margin came in at -476.19%, down 506.76 percentage points year-over-year; for FY2025, it was -29.35%, down 47.45 percentage points from FY2024.
- Operating Margin has a five-year change of +88.35 percentage points (FY2020 to FY2025).
- By year, Operating Margin came in at 18.10% in FY2024 (+24.51 pp), -6.41% in FY2023 (+184.21 pp), -190.61% in FY2022 (+120.39 pp) and -311.00% in FY2021 (-193.30 pp).
- Five-year quarterly Operating Margin spans a low of -4212.97% in Q4 2025 and a high of 46.41% in Q4 2024.
- Year over year, Operating Margin has now declined in each of the last four quarters, with an average year-over-year change of -793.78 percentage points over the last eight quarters.
- The high point for year-over-year Operating Margin in five years was Q1 2023 (a gain of 330.61 percentage points); the low point was Q4 2025 (a drop of 4259.38 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -191.77% (Q1 2026), -4212.97% (Q4 2025) and -264.43% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | CytomX Therapeutics | 599.22 Mn | -358.44 Mn | - | -1,677.08% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,677.08% |
| Mar 31, 2026 | -191.77% |
| Dec 31, 2025 | -4,212.97% |
| Sep 30, 2025 | -264.43% |
| Jun 30, 2025 | -6.89% |
| Mar 31, 2025 | 44.43% |
| Dec 31, 2024 | 46.41% |
| Sep 30, 2024 | 12.30% |
| Jun 30, 2024 | -33.65% |
| Mar 31, 2024 | 28.11% |
| Dec 31, 2023 | -2.28% |
| Sep 30, 2023 | 11.84% |
| Jun 30, 2023 | -13.54% |
| Mar 31, 2023 | -24.06% |
| Dec 31, 2022 | -47.25% |
| Sep 30, 2022 | -266.53% |
| Jun 30, 2022 | -233.83% |
| Mar 31, 2022 | -354.67% |
| Dec 31, 2021 | -313.54% |
| Sep 30, 2021 | -337.78% |
CytomX Therapeutics Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=CTMX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();